Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Rare Disease Drug Repurposing Datathon Launching
Posted on September 28th, 2018 by Jabe Wilson in Pharma R&D
Would you and your organization like to use your skills and expertise to help defeat rare diseases? On October 9, the Rare Disease Drug Repurposing Datathon is launching, offering data scientists a special opportunity to work together to uncover insights on rare conditions like chronic pancreatitis, Meniere’s disease, retinitis pigmentosa and obsessive-compulsive disorder (OCD).
In conjunction with our work with the Pistoia Alliance, the global partnership of commercial and academic groups working to lower barriers to innovation, Elsevier is providing Datathon participants with datasets relevant to the above-mentioned diseases. Participating teams will be utilizing the cutting-edge Entellect life sciences platform, which delivers connected and AI-ready data by linking and enriching disparate content against established life science taxonomies.
The work generated by participants in the Datathon will be passed on to Cures Within Reach, to benefit their efforts in drug repurposing for rare diseases. Cures Within Reach is a non-profit dedicated to alleviating suffering and bringing hope to those dealing with life-threatening illness, and inspiring and funding researchers with innovative ideas.
Want to learn more about the Datathon? Find out what to expect in the challenge, how to participate, and see the full Datathon timeline by clicking here.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
- AI in Drug Discovery Has Great Potential – But Also Significant Barriers
- Three factors to unlock the value of AI for life sciences
- Elsevier is recognized as ‘Best of Show Award Finalist’ and ‘Innovative Practices Finalist” at Bio-IT World Conference & Expo 2019
- Working together to get the best out of AI for all
- Data-Driven Technologies are Shaking Up the Drug Development Process